FI822921A0 - FREQUENCY REQUIREMENT FOR THE ADMINISTRATION OF AV / 3H / -IMIDAZO- / 5,1-D / -1,2,3,5-TETRAZINE-4-ONER - Google Patents

FREQUENCY REQUIREMENT FOR THE ADMINISTRATION OF AV / 3H / -IMIDAZO- / 5,1-D / -1,2,3,5-TETRAZINE-4-ONER

Info

Publication number
FI822921A0
FI822921A0 FI822921A FI822921A FI822921A0 FI 822921 A0 FI822921 A0 FI 822921A0 FI 822921 A FI822921 A FI 822921A FI 822921 A FI822921 A FI 822921A FI 822921 A0 FI822921 A0 FI 822921A0
Authority
FI
Finland
Prior art keywords
oner
tetrazine
imidazo
administration
frequency requirement
Prior art date
Application number
FI822921A
Other languages
Finnish (fi)
Other versions
FI73434B (en
FI822921L (en
FI73434C (en
Inventor
Edward Lunt
Malcolm Francis Graham Stevens
Robert Stone
Kenneth Robert Harr Wooldringe
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of FI822921A0 publication Critical patent/FI822921A0/en
Publication of FI822921L publication Critical patent/FI822921L/en
Publication of FI73434B publication Critical patent/FI73434B/en
Application granted granted Critical
Publication of FI73434C publication Critical patent/FI73434C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
FI822921A 1981-08-24 1982-08-23 Process for Preparation of 3H-imidazo-5,1-d FI73434C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24
GB8125791 1981-08-24

Publications (4)

Publication Number Publication Date
FI822921A0 true FI822921A0 (en) 1982-08-23
FI822921L FI822921L (en) 1983-02-25
FI73434B FI73434B (en) 1987-06-30
FI73434C FI73434C (en) 1987-10-09

Family

ID=10524141

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822921A FI73434C (en) 1981-08-24 1982-08-23 Process for Preparation of 3H-imidazo-5,1-d

Country Status (29)

Country Link
JP (1) JPS5843975A (en)
KR (1) KR890000094B1 (en)
AT (1) AT380256B (en)
AU (1) AU571430B2 (en)
BE (1) BE894175A (en)
CA (1) CA1197247A (en)
CH (1) CH655114A5 (en)
DE (2) DE3231255A1 (en)
DK (1) DK161147C (en)
ES (1) ES8400438A1 (en)
FI (1) FI73434C (en)
FR (1) FR2511679A1 (en)
GB (1) GB2104522B (en)
GE (1) GEP19960641B (en)
GR (1) GR76863B (en)
HU (1) HU186107B (en)
IE (1) IE53408B1 (en)
IL (1) IL66606A (en)
IT (1) IT1152505B (en)
LT (1) LT2436B (en)
LU (1) LU84347A1 (en)
LV (2) LV5511A3 (en)
NL (2) NL192739C (en)
NZ (1) NZ201668A (en)
OA (1) OA07174A (en)
SE (1) SE448543B (en)
SU (1) SU1447284A3 (en)
UA (1) UA5971A1 (en)
ZA (1) ZA826120B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
FR2531958B1 (en) * 1982-08-17 1986-10-31 May & Baker Ltd NEW DERIVATIVES
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
WO2005063757A2 (en) * 2003-12-30 2005-07-14 Chemagis Ltd. Novel crystalline forms of temozolomide
WO2006077428A1 (en) 2005-01-21 2006-07-27 Astex Therapeutics Limited Pharmaceutical compounds
PE20080695A1 (en) 2006-04-27 2008-06-28 Banyu Pharma Co Ltd DIHYDROPIRAZOLOPYRIMIDINONE DERIVATIVES AS KINASE WEEL INHIBITORS
JP2008081492A (en) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd New aminopyridine derivative having aurora a selective inhibitory action
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
CA2703489A1 (en) 2007-10-23 2009-04-30 Banyu Pharmaceutical Co., Ltd. Pyridone-substituted-dihydropyrazolopyrimidinone derivative
PE20091101A1 (en) * 2007-12-18 2009-07-26 Pharminox Ltd 3-SUBSTITUTED-4-OXO-3,4-DIHYDRO-IMIDAZO [5,1-d] [1,2,3,5-TETRACINE-8-CARBOXYL ACID AMIDES AND ITS USE
JP2012509868A (en) * 2008-11-24 2012-04-26 リライアンス ライフ サイエンシズ ピーヴィーティー リミティッド Method for producing tetrazine derivative
WO2010101734A1 (en) 2009-03-06 2010-09-10 Merck Sharp & Dohme Corp. Combination cancer therapy with an akt inhibitor and other anticancer agents
PL2445915T3 (en) 2009-06-23 2016-10-31 3-substituted-8-substituted-3h imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
RU2462466C1 (en) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Substituted azolo[1,2,4,5]tetrazines - inhibitors of antibacterial serine-threonine protein kinases
US20140271657A1 (en) 2011-10-12 2014-09-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
IL261721B (en) 2016-03-15 2022-07-01 Oryzon Genomics Sa Combinations of lsd1 inhibitors for use in the treatment of solid tumors
KR101847342B1 (en) * 2017-05-08 2018-04-11 (주)센텍코리아 Wearable body fat burning measurement device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (en) * 1979-08-09 1981-02-26 Basf Ag Pyrrolo-, pyrazolo-, imidazo- and thiazolo-tetrazin-4-one derivs. - prepd. from amino-azole cpds. by diazotisation and reaction with isocyanate

Also Published As

Publication number Publication date
SE8204817L (en) 1983-02-25
HU186107B (en) 1985-06-28
DE19975037I2 (en) 2001-06-13
NL192739C (en) 1998-01-06
AU571430B2 (en) 1988-04-21
JPS5843975A (en) 1983-03-14
CH655114A5 (en) 1986-03-27
AT380256B (en) 1986-05-12
GR76863B (en) 1984-09-04
UA5971A1 (en) 1994-12-29
CA1197247A (en) 1985-11-26
ES515176A0 (en) 1983-11-01
JPH045029B2 (en) 1992-01-30
IT1152505B (en) 1987-01-07
FI73434B (en) 1987-06-30
LV5621A3 (en) 1994-05-10
KR840001175A (en) 1984-03-28
NL990010I1 (en) 1999-07-01
DK161147C (en) 1991-11-18
DK161147B (en) 1991-06-03
IE53408B1 (en) 1988-11-09
LV5511A3 (en) 1994-03-10
SU1447284A3 (en) 1988-12-23
DE3231255C2 (en) 1992-02-27
ATA319182A (en) 1985-09-15
NL990010I2 (en) 1999-09-01
SE8204817D0 (en) 1982-08-23
FI822921L (en) 1983-02-25
DK377882A (en) 1983-02-25
FI73434C (en) 1987-10-09
SE448543B (en) 1987-03-02
LU84347A1 (en) 1983-06-07
IE822026L (en) 1983-02-24
FR2511679B1 (en) 1985-02-01
IL66606A (en) 1987-07-31
BE894175A (en) 1983-02-23
LT2436B (en) 1994-02-15
FR2511679A1 (en) 1983-02-25
AU8749382A (en) 1983-03-03
GB2104522B (en) 1985-06-12
IT8222938A0 (en) 1982-08-23
GB2104522A (en) 1983-03-09
NZ201668A (en) 1985-08-16
OA07174A (en) 1984-04-30
ZA826120B (en) 1983-07-27
DE3231255A1 (en) 1983-03-03
KR890000094B1 (en) 1989-03-07
NL192739B (en) 1997-09-01
ES8400438A1 (en) 1983-11-01
NL8203286A (en) 1983-03-16
GEP19960641B (en) 1996-11-15
IL66606A0 (en) 1982-12-31

Similar Documents

Publication Publication Date Title
FI822921A0 (en) FREQUENCY REQUIREMENT FOR THE ADMINISTRATION OF AV / 3H / -IMIDAZO- / 5,1-D / -1,2,3,5-TETRAZINE-4-ONER
NO821087L (en) PROCEDURE FOR THE PREPARATION OF CYCLOBUTAN DERIVATIVES.
NO822556L (en) PROCEDURE FOR THE PREPARATION OF INHALATION MEDICINES
NO821137L (en) PROCEDURE FOR THE PREPARATION OF TERTIARY ALKYLETERS
NO874764L (en) PROCEDURE FOR THE PREPARATION OF 2-AMINOPURIN DERIVATIVES.
FI870919A (en) ANORDINATION FOR THE DEFINITION OF MEMBRANDESTILLATION.
NO165027C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVAL PROPENYL-CEPHALOSPOR COMPOUNDS.
NO155693C (en) PROCEDURE FOR THE PREPARATION OF EBURNAMONIN DERIVATIVES.
NO822634L (en) PROCEDURE FOR THE MANUFACTURE OF CEFEM DERIVATIVES.
FI820598L (en) PROCEDURE FOR THE FRAMSTATION OF TREO-2-HYDROXY-3- (4-METHOXIFENYL) -3- (2-NITROPHENYLTHIO) -PROPIONSYRAESTER
NO855067L (en) PROCEDURE FOR THE PREPARATION OF N-FORMYL-ALFA-ASPARTYL-PHENYLALANINE.
NO820010L (en) ORGANOPOLYSILOXAN MIXTURES SUITABLE FOR THE PREPARATION OF ELASTOMERS
NO851920L (en) PROCEDURE FOR THE PREPARATION OF IMIDAZO-RIFAMYCIN DERIVATIVES.
YU49482A (en) Process for the manufacture of guanidine derivatives
NO874268L (en) PROCEDURE FOR THE PREPARATION OF N-SUBSTITUTED PIPERAZINONS.
NO163010C (en) PROCEDURE FOR THE PREPARATION OF N-SULFAMYL-3- (2-GUANIDINO-THIAZOLO-4-YL-METHYLTHIO) -PROPIONAMIDE.
NO165637C (en) PROCEDURE FOR THE PREPARATION OF ETHOXYLED LIGINITE.
NO164773C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF COMPOUNDS WITH PHARMACEUTICAL EFFECT.
NO871721D0 (en) PROCEDURE FOR THE MANUFACTURE OF ERGOLEN DERIVATIVES.
NO821686L (en) PROCEDURE FOR THE PREPARATION OF PENICILLIN DERIVATIVES
ES518725A0 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF AZABICICLO (3.2.0) HEPTANE.
JPS57181100A (en) Manufacture of 17 alpha-hydroxy-pregn-4-ene- 3,20-dione derivatives
FI820923L (en) PROCEDURE FOR THE FRAMSTATION OF AV 2-AMINO-5- (O-SULPHAMIDOPHENYL) -1,3,4-THIADIAZOLDERIVAT
NO161561C (en) PROCEDURE FOR THE PREPARATION OF 4 (3H) PYRIMIDONS.
NO821874L (en) PROCEDURE FOR THE PREPARATION OF PHENOLETERS.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: CANCER RESEARCH CAMPAIGN TECHNOLOGY

SPCG Supplementary protection certificate granted

Spc suppl protection certif: L114

Extension date: 20070822

MA Patent expired

Owner name: CANCER RESEARCH CAMPAIGN TECHNOLOGY